Skip to main content
Clinical Trials/NCT04660279
NCT04660279
Completed
Not Applicable

Dynamic Wholebody FDG PET/CT - Next Generational Functional Imaging: Optimization and Validation of Data Acquisition

Aarhus University Hospital1 site in 1 country20 target enrollmentJanuary 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Positron-Emission Tomography
Sponsor
Aarhus University Hospital
Enrollment
20
Locations
1
Primary Endpoint
Time reduction of current parametric reconstruction protocol
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Quantification of the metabolic rate of glucose from Dynamic Whole-Body PET examinations requires measurements of the time course of the radioactivity concentrations in arterial blood by blood sampling, and in the tissue of interest by dynamic PET. Invasive arterial blood sampling cannot be part of a standard examination, and therefore the blood samples need to be replaced by activity concentrations derived from the PET images, usually from small volumes in the descending aorta or left ventricle.

Newly developed scanner software (Siemens) allows automated CT-based identification of blood pool regions and extraction of an image-derived blood input function from the corresponding PET data.

However, this automated method needs validation, as it could be prone to systematic errors caused by limited spatial resolution, patient movement, and image reconstruction. We will use invasively measured arterial blood samples as a reference for validation of methods to extract non-invasive PET image-derived input functions and quantify any systematic errors that could propagate to the resulting parametric images.

Registry
clinicaltrials.gov
Start Date
January 1, 2020
End Date
December 31, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Aarhus University Hospital
Responsible Party
Principal Investigator
Principal Investigator

André H. Dias

Staff specialist, PhD Student

Aarhus University Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients with a planned clinical standard PET/CT as part of pre-therapeutic staging, response assessment scanning.
  • Good performance status, which will allow us to obtain informed consent to draw the required arterial blood samples during the examination, and which will permit patients to lay still in the scanner for at least 70 min.

Exclusion Criteria

  • • Age \< 18 or \> 85 years
  • Patients that can not tolerate a PET scan (f.ex: claustrophobia).

Outcomes

Primary Outcomes

Time reduction of current parametric reconstruction protocol

Time Frame: through study completion, an average of 1 year

After we have validated the image derived input function we will use the data we sampled to construct a "normal population" input function that can be applied to the current protocol. This way we will be able to skip the acquisition on the camera of the input function and be able to only scan the patients at a later period, therefor shortening the acquisition protocol to something more manageable in daily clinic.

Validation of current parametric reconstruction protocol

Time Frame: through study completion, an average of 1 year

We will perform a correlation of the image derived input function and the input function obtained from blood sampling. This will allow us to confirm that the information obtained by the equipment is accurate enough and can be trusted.

Study Sites (1)

Loading locations...

Similar Trials